NCT02260180View on ClinicalTrials.gov

Study of A-101 for the Treatment of Seborrheic Keratosis

PHASE2CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Seborrheic Keratosis
Interventions
DRUG

A-101

Topical Solution

Trial Locations (4)

19034

Philadelphia Institute of Dermatology, Fort Washington

24501

The Education & Research Foundation, Inc., Lynchburg

78759

DermReseach, Inc., Austin

97223

Oregon Medical Research Center, Portland

Sponsors
All Listed Sponsors
lead

Aclaris Therapeutics, Inc.

INDUSTRY